Dr. Luigina Mollica - CML - Chronic Myeloid Leukemia
Hematologist at Maisonneuve-Rosemont Hospital
Associate of the Royal College of Physicians of Canada in internal medicine, hematology and medical oncology (FRCPC)
Assistant Clinical Professor, Department of Medicine, University of Montreal
Director of clinical research in hematology at Hôpital Maisonneuve-Rosemont
Treasurer of the Groupe québécois de recherche en leucémie myéloïde chronique et en néoplasies myéloprolifératives (GQR-LMC-NMP)
More information at Research Centre of the Maisonneuve-Rosemont Hospital (HMR)
ARTICLES
Reversible lymph node follicular hyperplasia associated with dasatinib treatment of chronic myeloid leukemia in chronic phase
October 24, 2013, Journal Blood
Role of a 5_-enhancer in the transcriptional regulation of the human endothelial cell protein C receptor gene
August 15, 2006, Journal Blood
Reversible lymph node follicular hyperplasia associated with dasatinib treatment of chronic myeloid leukemia in chronic phase
October 24, 2013, Journal Blood
Role of a 5_-enhancer in the transcriptional regulation of the human endothelial cell protein C receptor gene
August 15, 2006, Journal Blood